| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780374 | Gynecologic Oncology | 2018 | 8 Pages |
Abstract
P53 and ASRGL1 immunoprofiling stratifies EEC patients into three risk groups with significantly different outcomes. This simple and easily applicable panel could provide a useful tool in EEC risk stratification and guiding the allocation of treatment modalities.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jutta Huvila, Teemu D. Laajala, Per-Henrik Edqvist, Adil Mardinoglu, Lauri Talve, Fredrik Pontén, Seija Grénman, Olli Carpén, Tero Aittokallio, Annika Auranen,